From the Journals

Ten reasons airborne transmission of SARS-CoV-2 appears airtight


 

Response to a review

The top 10 list is also part rebuttal of a systematic review funded by the WHO and published last month that points to inconclusive evidence for airborne transmission. The researchers involved with that review state that “the lack of recoverable viral culture samples of SARS-CoV-2 prevents firm conclusions to be drawn about airborne transmission.”

However, Dr. Greenhalgh and colleagues note that “this conclusion, and the wide circulation of the review’s findings, is concerning because of the public health implications.”

The current authors also argue that enough evidence already exists on airborne transmission. “Policy should change. We don’t need more research on this topic; we need different policy,” Dr. Greenhalgh said. “We need ventilation front and center, air filtration when necessary, and better-fitting masks worn whenever indoors.”

Dr. Allen agreed that guidance hasn’t always kept pace with the science. “With all of the new evidence accumulated on airborne transmission since last winter, there is still widespread confusion in the public about modes of transmission,” he said. Dr. Allen also serves as commissioner of The Lancet COVID-19 Commission and is chair of the commission’s Task Force on Safe Work, Safe Schools, and Safe Travel.

“It was only just last week that CDC pulled back on guidance on ‘deep cleaning’ and in its place correctly said that the risk from touching surfaces is low,” he added. “The science has been clear on this for over a year, but official guidance was only recently updated.”

As a result, many companies and organizations continued to focus on “hygiene theatre,” Dr. Allen said, “wasting resources on overcleaning surfaces. Unbelievably, many schools still close for an entire day each week for deep cleaning and some still quarantine library books. The message that shared air is the problem, not shared surfaces, is a message that still needs to be reinforced.”

The National Institute for Health Research, Economic and Social Research Council, and Wellcome support Dr. Greenhalgh’s research. Dr. Greenhalgh and Dr. Allen had no relevant financial relationships to disclose.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

FDA, CDC urge pause of J&J COVID vaccine
MDedge Endocrinology
Remote cardio visits expand access for underserved during COVID
MDedge Endocrinology
Next winter may be rough: Models predict ‘considerable surge’ of COVID
MDedge Endocrinology
Data about COVID-19-related skin manifestations in children continue to emerge
MDedge Endocrinology
How to counsel worried patients about the J&J vaccine news
MDedge Endocrinology
How some COVID-19 vaccines could cause rare blood clots
MDedge Endocrinology
CDC panel: Pause of J&J COVID-19 vaccine to remain for now
MDedge Endocrinology
COVID-19 vaccine response lower in kidney dialysis patients
MDedge Endocrinology
Pneumonia risk soars in heart failure patients, especially HFpEF
MDedge Endocrinology
Twenty percent of dialysis patients are hesitant about COVID-19 vaccine
MDedge Endocrinology